JPWO2022101435A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022101435A5
JPWO2022101435A5 JP2023528637A JP2023528637A JPWO2022101435A5 JP WO2022101435 A5 JPWO2022101435 A5 JP WO2022101435A5 JP 2023528637 A JP2023528637 A JP 2023528637A JP 2023528637 A JP2023528637 A JP 2023528637A JP WO2022101435 A5 JPWO2022101435 A5 JP WO2022101435A5
Authority
JP
Japan
Prior art keywords
compound
adhd
use according
administered
moxonidine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023528637A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023549394A (ja
Publication date
Priority claimed from GBGB2017858.8A external-priority patent/GB202017858D0/en
Priority claimed from GBGB2103400.4A external-priority patent/GB202103400D0/en
Application filed filed Critical
Priority claimed from PCT/EP2021/081567 external-priority patent/WO2022101435A1/en
Publication of JP2023549394A publication Critical patent/JP2023549394A/ja
Publication of JPWO2022101435A5 publication Critical patent/JPWO2022101435A5/ja
Pending legal-status Critical Current

Links

JP2023528637A 2020-11-12 2021-11-12 注意欠陥／多動性障害の新規な治療 Pending JP2023549394A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB2017858.8 2020-11-12
GBGB2017858.8A GB202017858D0 (en) 2020-11-12 2020-11-12 Novel treatments
GBGB2103400.4A GB202103400D0 (en) 2021-03-11 2021-03-11 Novel treatments
GB2103400.4 2021-03-11
PCT/EP2021/081567 WO2022101435A1 (en) 2020-11-12 2021-11-12 Novel treatments of attention deficit/hyperactivity disorder

Publications (2)

Publication Number Publication Date
JP2023549394A JP2023549394A (ja) 2023-11-24
JPWO2022101435A5 true JPWO2022101435A5 (enrdf_load_stackoverflow) 2024-11-19

Family

ID=78649316

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023528637A Pending JP2023549394A (ja) 2020-11-12 2021-11-12 注意欠陥／多動性障害の新規な治療

Country Status (4)

Country Link
US (1) US20240002369A1 (enrdf_load_stackoverflow)
EP (1) EP4243826A1 (enrdf_load_stackoverflow)
JP (1) JP2023549394A (enrdf_load_stackoverflow)
WO (1) WO2022101435A1 (enrdf_load_stackoverflow)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023084054A1 (en) * 2021-11-12 2023-05-19 3Z Ehf Treatment of adhd using selective binders of the 11-imidazoline receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4323570A (en) 1978-11-15 1982-04-06 Beiersdorf Aktiengesellschaft Substituted aminopyrimidines
WO2004009090A1 (en) * 2002-07-18 2004-01-29 Vanderbilt University Therapeutic and screening methods employing partial agonism of the ∝-2a adrenergic receptor subtype
CN101370500A (zh) * 2006-01-27 2009-02-18 弗·哈夫曼-拉罗切有限公司 2-咪唑化合物用于治疗cns障碍的用途

Similar Documents

Publication Publication Date Title
US11413258B2 (en) Methods for treating cancer
US8318811B2 (en) Method for treating an inflammatory bowel disease using 2-amino-2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]ethyl-1,3-propanediol or a salt thereof
BRPI0914985B1 (pt) Composição para administração oral de baixa dose de topiramato/fentermina
EP1988898A2 (en) Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin
RU2493840C2 (ru) Лечение аутоиммунных заболеваний
EA002689B1 (ru) Способ лечения оппозиционного расстройства
JP4800936B2 (ja) ヒスタミンレセプターｈ３のアンタゴニスト又は逆アゴニスト及び抗生精神病又は抗うつ病剤を含んで成る組み合わせ産物、並びにそれらの抗精神薬の不都合な効果を予防する医薬を調製するための使用
HUT71222A (en) Pharmaceutical compositions for inhibiting pulmonary hypertenzive diseases containing 2-phenyl-3-aroyl-benzotiophene derivatives and process for their preparation
BR112019026474A2 (pt) compostos para tratar tnbc
JP6784407B2 (ja) 近視予防剤及び近視進行抑制剤
KR20170131242A (ko) 섬유근육통 또는 섬유근육통의 연관된 기능적 증후군을 예방 또는 치료하기 위한 카바메이트 화합물의 용도
RU2008108175A (ru) Комбинация соединений, которые можно использовать при лечении респираторных заболеваний, особенно хронической оструктивной болезни легких (copo) и астмы
US6683114B2 (en) Treatment of psoriasis
JP4246997B2 (ja) 糖尿病由来虚血性心疾患の治療及び／または予防剤
JPH02138214A (ja) 不安を治療する方法
JPWO2022101435A5 (enrdf_load_stackoverflow)
JP7601458B2 (ja) スフィンゴシン－１－リン酸受容体アゴニストの使用
JP2015506988A (ja) 半減期の短い選択的エストロゲン受容体モジュレーターおよびその使用
EA010868B1 (ru) Применение производных бицикло[2.2.1]гептана для приготовления нейропротекторных фармацевтических композиций
CN117412751A (zh) 用于预防或治疗肺纤维化的药物制剂
JPH02138173A (ja) 繊維筋痛症の治療
JPWO2020037152A5 (enrdf_load_stackoverflow)
WO2023178255A9 (en) Combinations comprising metap2 inhibitors for the treatment of cancer
CN116490191A (zh) 治疗胆汁淤积性瘙痒的方法
WO2020044067A1 (en) Pharmaceutical combination to modify the effect of beta-receptor blockers and reduce side effects